also known as tau protein kinase I), CDK5 (cyclin-dependent kinase 5, also known as tau protein kinase II) and ERK2 (extracellular signal-regulated kinase 2) — that could be used to achieve this ...

LEXINGTON, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today ...